Clean Boxing Program: Cortisone

In the demanding world of professional boxing, where every advantage can make the difference between victory and defeat, the use of certain substances is strictly regulated.

One such substance is cortisone, a powerful anti-inflammatory that, despite its widespread medical use, is prohibited by the Voluntary Anti-Doping Association (VADA) during competition.

Cortisone belongs to the group of glucocorticoids, medications that rapidly and effectively reduce pain and inflammation. However, its use in combat can mask serious injuries, allowing a fighter to continue even with compromised physical conditions. Additionally, it suppresses the feeling of fatigue and improves pain endurance, which constitutes an unnatural competitive advantage.

According to anti-doping regulations, cortisone is prohibited when administered through systemic routes—meaning orally, intravenously, or intramuscularly—during the competition period. Nevertheless, its use may be permitted outside of competition or with a Therapeutic Use Exemption (TUE), provided it is properly justified and notified to VADA.

Beyond performance, the indiscriminate use of corticosteroids can lead to adverse effects such as insomnia, high blood pressure, mood swings, and even muscle or joint damage.

The Clean Boxing Program maintains its firm stance: to protect the athlete’s health and ensure fair competition. In that regard, cortisone, though medically useful, has no place in a boxing ring without proper controls.

If you want to view the list of prohibited substances issued by VADA, you can consult the following link: https://wbcboxing.com/wp-content/uploads/2025/VADA-Prohibited-List-2025.pdf